A detailed history of Nuveen Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,702,612 shares of AZN stock, worth $133 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,702,612
Previous 3,651,170 53.37%
Holding current value
$133 Million
Previous $246 Million 53.09%
% of portfolio
0.04%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $119 Million - $136 Million
-1,948,558 Reduced 53.37%
1,702,612 $115 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $104 Million - $116 Million
-1,675,192 Reduced 31.45%
3,651,170 $246 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $102 Million - $113 Million
-1,576,674 Reduced 22.84%
5,326,362 $361 Million
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $9.17 Million - $9.94 Million
-131,152 Reduced 1.86%
6,903,036 $494 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $66.3 Million - $75.2 Million
-1,050,494 Reduced 12.99%
7,034,188 $488 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $34.3 Million - $44.6 Million
633,004 Added 8.49%
8,084,682 $548 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $3.97 Million - $10.2 Million
-74,846 Reduced 0.99%
7,451,678 $409 Million
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $33.9 Million - $40.7 Million
-572,654 Reduced 7.07%
7,526,524 $497 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $17.7 Million - $21.3 Million
317,164 Added 4.08%
8,099,178 $537 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $25.6 Million - $30.3 Million
-474,462 Reduced 5.75%
7,782,014 $453 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $157 Million - $171 Million
2,820,586 Added 51.89%
8,256,476 $496 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $88.6 Million - $110 Million
1,830,576 Added 50.77%
5,435,890 $326 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $31.4 Million - $36.3 Million
666,137 Added 22.66%
3,605,314 $179 Million
Q4 2020

May 17, 2021

BUY
$48.52 - $58.02 $62.4 Million - $74.6 Million
1,285,852 Added 77.77%
2,939,177 $147 Million
Q4 2020

Feb 16, 2021

SELL
$48.52 - $58.02 $25.5 Million - $30.4 Million
-524,695 Reduced 24.09%
1,653,325 $82.7 Million
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $15 Million - $17.2 Million
-282,183 Reduced 11.47%
2,178,020 $119 Million
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $13.6 Million - $17.4 Million
314,451 Added 14.65%
2,460,203 $130 Million
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $20.8 Million - $28.3 Million
550,742 Added 34.53%
2,145,752 $95.8 Million
Q4 2019

Feb 14, 2020

BUY
$42.46 - $50.46 $27.9 Million - $33.1 Million
656,269 Added 69.91%
1,595,010 $79.5 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $19.3 Million - $21.9 Million
482,147 Added 105.6%
938,741 $41.8 Million
Q2 2019

Aug 15, 2019

BUY
$37.28 - $41.68 $17 Million - $19 Million
456,594 New
456,594 $18.8 Million
Q1 2018

May 14, 2018

SELL
$32.97 - $36.63 $233,031 - $258,900
-7,068 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $4,524 - $4,903
141 Added 2.04%
7,068 $0
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $200,605 - $235,518
6,927
6,927 $235,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.